Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$57.03
+0.5%
$58.74
$42.52
$62.89
$116.41B0.2612.26 million shs6.31 million shs
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
$482.99
-0.2%
$479.98
$455.18
$516.85
$1.04T0.634.84 million shs3.21 million shs
Equifax, Inc. stock logo
EFX
Equifax
$158.19
+0.3%
$181.47
$156.47
$281.03
$18.83B1.351.81 million shs774,304 shs
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
$24.63
-1.7%
$24.78
$22.55
$28.42
$8.95B1.127.29 million shs82.08 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.30
-1.8%
$27.01
$22.45
$28.75
$144.00B0.3542.33 million shs26.88 million shs
The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
+0.64%+1.03%-2.28%-6.39%+28.83%
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
-0.25%+1.99%+1.34%-2.69%-3.87%
Equifax, Inc. stock logo
EFX
Equifax
-1.38%-10.12%-15.35%-18.09%-41.89%
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
0.00%0.00%0.00%0.00%-1.48%
Pfizer Inc. stock logo
PFE
Pfizer
-0.83%-2.78%-5.12%-6.65%+16.95%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$57.03
+0.5%
$58.74
$42.52
$62.89
$116.41B0.2612.26 million shs6.31 million shs
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
$482.99
-0.2%
$479.98
$455.18
$516.85
$1.04T0.634.84 million shs3.21 million shs
Equifax, Inc. stock logo
EFX
Equifax
$158.19
+0.3%
$181.47
$156.47
$281.03
$18.83B1.351.81 million shs774,304 shs
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
$24.63
-1.7%
$24.78
$22.55
$28.42
$8.95B1.127.29 million shs82.08 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.30
-1.8%
$27.01
$22.45
$28.75
$144.00B0.3542.33 million shs26.88 million shs
The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
+0.64%+1.03%-2.28%-6.39%+28.83%
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
-0.25%+1.99%+1.34%-2.69%-3.87%
Equifax, Inc. stock logo
EFX
Equifax
-1.38%-10.12%-15.35%-18.09%-41.89%
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
0.00%0.00%0.00%0.00%-1.48%
Pfizer Inc. stock logo
PFE
Pfizer
-0.83%-2.78%-5.12%-6.65%+16.95%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2.37
Hold$61.317.51% Upside
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
2.00
Hold$524.508.59% Upside
Equifax, Inc. stock logo
EFX
Equifax
2.68
Moderate Buy$228.0644.16% Upside
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
2.20
Hold$28.7016.52% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.23
Hold$28.8414.02% Upside

Current Analyst Ratings Breakdown

Latest IPG, EFX, BMY, PFE, and BRK.B Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingUnderperform$26.00
5/8/2026
Equifax, Inc. stock logo
EFX
Equifax
Lower Price Target$226.00 ➝ $214.00
5/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C-)Hold (C)
5/4/2026
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
Lower Price TargetBuy$581.00 ➝ $570.00
5/1/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Reiterated RatingNeutral
4/29/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetNeutral$26.00 ➝ $27.00
4/27/2026
Equifax, Inc. stock logo
EFX
Equifax
Lower Price TargetNeutral$210.00 ➝ $195.00
4/23/2026
Equifax, Inc. stock logo
EFX
Equifax
Lower Price TargetBuy$245.00 ➝ $220.00
4/23/2026
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
Boost Price TargetBuy$578.00 ➝ $581.00
4/22/2026
Equifax, Inc. stock logo
EFX
Equifax
Lower Price TargetOverweight$244.00 ➝ $243.00
4/22/2026
Equifax, Inc. stock logo
EFX
Equifax
Lower Price TargetBuy$256.00 ➝ $238.00
(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$48.19B2.42$8.23 per share6.93$9.84 per share5.80
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
$371.44B2.80$26.73 per share18.07$338.20 per share1.43
Equifax, Inc. stock logo
EFX
Equifax
$6.07B3.10$13.78 per share11.48$38.32 per share4.13
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
$10.21B0.88$4.11 per share5.99$10.37 per share2.38
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.30$4.29 per share5.90$15.86 per share1.59
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$7.05B$3.5616.019.430.1615.01%64.87%13.16%7/30/2026 (Estimated)
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
$66.97B$33.5914.3822.70N/A19.31%6.55%3.80%N/A
Equifax, Inc. stock logo
EFX
Equifax
$660.30M$5.6827.8415.371.2011.12%20.41%8.27%7/21/2026 (Estimated)
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
$689.50M$1.4720.878.67N/A4.27%28.72%6.22%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.298.84N/A11.83%19.44%8.41%N/A

Latest IPG, EFX, BMY, PFE, and BRK.B Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
5/2/2026Q1 2026
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
$4.82$5.25+$0.43$5.82$95.10 billion$93.68 billion
4/30/2026Q1 2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$1.42$1.58+$0.16$1.31$10.93 billion$11.49 billion
4/21/2026Q1 2026
Equifax, Inc. stock logo
EFX
Equifax
$1.69$1.86+$0.17$1.42$1.61 billion$1.65 billion
2/28/2026Q4 2025
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
$5.19$4.73-$0.46$0.56$102.89 billion$94.23 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$2.524.42%+1.61%70.79%17 Years
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
N/AN/AN/AN/AN/A
Equifax, Inc. stock logo
EFX
Equifax
$2.241.42%+3.91%39.44%1 Years
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
$1.325.36%+7.03%89.80%13 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.80%-13.20%131.30%16 Years

Latest IPG, EFX, BMY, PFE, and BRK.B Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2026
Equifax, Inc. stock logo
EFX
Equifax
quarterly$0.561.28%5/22/20265/22/20266/15/2026
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
3/2/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
quarterly$0.634.23%4/2/20264/2/20265/1/2026
2/25/2026
Equifax, Inc. stock logo
EFX
Equifax
quarterly$0.561.09%3/9/20263/9/20263/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2.10
1.42
1.28
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
N/A
0.36
0.36
Equifax, Inc. stock logo
EFX
Equifax
0.89
0.61
0.61
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
0.78
1.07
1.07
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94

Institutional Ownership

CompanyInstitutional Ownership
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
76.41%
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
39.25%
Equifax, Inc. stock logo
EFX
Equifax
96.20%
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
98.43%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.05%
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
6.05%
Equifax, Inc. stock logo
EFX
Equifax
1.70%
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
0.42%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
32,5002.04 billion2.04 billionOptionable
Berkshire Hathaway Inc. stock logo
BRK.B
Berkshire Hathaway
387,8002.16 billion2.03 billionOptionable
Equifax, Inc. stock logo
EFX
Equifax
15,000119.07 million117.05 millionOptionable
Interpublic Group of Companies, Inc. (The) stock logo
IPG
Interpublic Group of Companies
53,300363.33 million364.73 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Pfizer Inc. $PFE Shares Sold by Pinnacle Associates Ltd.
Assorted pharmaceutical pills, a medicine vial, and a syringe arranged on a laboratory bench.
2 Ways to Play the Big Pharma Patent Cliff (PFE)
...
Pfizer's Turnaround Is Taking Shape

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bristol Myers Squibb stock logo

Bristol Myers Squibb NYSE:BMY

$57.03 +0.26 (+0.46%)
As of 03:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Berkshire Hathaway stock logo

Berkshire Hathaway NYSE:BRK.B

$482.99 -1.07 (-0.22%)
As of 03:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Berkshire Hathaway Inc., through its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses worldwide. The company provides property, casualty, life, accident, and health insurance and reinsurance; and operates railroad systems in North America. It also generates, transmits, stores, and distributes electricity from natural gas, coal, wind, solar, hydroelectric, nuclear, and geothermal sources; operates natural gas distribution and storage facilities, interstate pipelines, liquefied natural gas facilities, and compressor and meter stations; and holds interest in coal mining assets. In addition, the company manufactures boxed chocolates and other confectionery products; specialty chemicals, metal cutting tools, and components for aerospace and power generation applications; flooring products; insulation, roofing, and engineered products; building and engineered components; paints and coatings; and bricks and masonry products, as well as offers manufactured and site-built home construction, and related lending and financial services. Further, it provides recreational vehicles, apparel and footwear products, jewelry, and custom picture framing products, as well as alkaline batteries; castings, forgings, fasteners/fastener systems, aerostructures, and precision components; and cobalt, nickel, and titanium alloys. Additionally, the company distributes televisions and information; franchises and services quick service restaurants; distributes electronic components; and offers logistics services, grocery and foodservice distribution services, and professional aviation training and shared aircraft ownership programs. It also retails automobiles; furniture, bedding, and accessories; household appliances, electronics, and computers; jewelry, watches, crystal, china, stemware, flatware, gifts, and collectibles; kitchenware; and motorcycle clothing and equipment. The company was incorporated in 1998 and is headquartered in Omaha, Nebraska.

Equifax stock logo

Equifax NYSE:EFX

$158.19 +0.47 (+0.30%)
As of 03:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Equifax Inc. operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship. The USIS segment provides consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting services; mortgage services; financial marketing services; identity management services; and credit monitoring products. The International segment offers information service products, which include consumer and commercial services, such as credit and financial information, and credit scoring and modeling; and credit and other marketing products and services, as well as offers information, technology, and other services to support debt collections and recovery management. The company serves customers in financial services, mortgage, retail, telecommunications, utilities, automotive, brokerage, healthcare, and insurance industries, as well as government agencies. It operates in Argentina, Australia, Brazil, Canada, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Honduras, India, Ireland, Mexico, New Zealand, Paraguay, Peru, Portugal, Spain, the United Kingdom, Uruguay, and the United States. The company was founded in 1899 and is headquartered in Atlanta, Georgia.

Interpublic Group of Companies stock logo

Interpublic Group of Companies NYSE:IPG

The Interpublic Group of Companies, Inc. provides advertising and marketing services worldwide. It operates in three segments: Media, Data & Engagement Solutions, Integrated Advertising & Creativity Led Solutions, and Specialized Communications & Experiential Solutions. The Media, Data & Engagement Solutions segment provides media and communications services, digital services and products, advertising and marketing technology, e-commerce services, data management and analytics, strategic consulting, and digital brand experience under the IPG Mediabrands, UM, Initiative, Kinesso, Acxiom, Huge, MRM, and R/GA brand names. The Integrated Advertising & Creativity Led Solutions segment offers advertising, corporate, and brand identity services; and strategic consulting under FCB, IPG Health, McCann Worldgroup, and MullenLowe Group brands. Specialized Communications & Experiential Solutions segment provides public relations and other specialized communications services, live events, sports and entertainment marketing, and strategic consulting under IPG DXTRA Health, The Weber Shandwick Collective, Golin, Jack Morton, Momentum, and Octagon brand names. The company was formerly known as McCann-Erickson Incorporated and changed its name to The Interpublic Group of Companies, Inc. in January 1961. The Interpublic Group of Companies, Inc. was founded in 1902 and is headquartered in New York, New York.

Pfizer stock logo

Pfizer NYSE:PFE

$25.30 -0.46 (-1.77%)
As of 03:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.